Alec Van Gelder: Novo Nordisk Opens Global Patient Advocacy Role for Haemoglobinopathies
Alec Van Gelder, Vice President of Corporate Affairs, Rare Disease at Novo Nordisk, shared a post on LinkedIn:
“We’re Hiring: Associate Director, Patient Advocacy – Haemoglobinopathies at Novo Nordisk Rare Disease.
With recent progress in Sickle Cell Disease marking a pivotal moment for the haemoglobinopathy community, there has never been a more important time to help shape what comes next for patients.
We are looking for a passionate and experienced Associate Director of Patient Advocacy to partner with the haemoglobinopathies community and lead our global patient advocacy work — ensuring that the voices of those living with conditions like SCD and thalassemia sit at the very heart of Novo Nordisk’s access strategy and external engagement.
If you have a passion for improving the lives of people living with sickle cell disease and thalassemia, we would love to hear from you.
Apply now and be part of the story we are writing together with the haemoglobinopathy community.”
Stay updated with Hemostasis Today.
-
Jul 4, 2026, 09:44Ettore Nicolini: Optimizing First-Pass Reperfusion in Basilar Artery Occlusion
-
Jul 4, 2026, 09:15Niroshani Young: The Essentials of Safe Blood Component Transfusion
-
Jul 4, 2026, 08:48Satarupa Choudhuri: Personalizing Anticoagulation Duration After VTE
-
Jul 4, 2026, 07:41Reem Alotaibi: Hexokinase as a Regulator of Platelet Metabolism and Function
-
Jul 4, 2026, 07:10Andrew Zapfel: A New WHO Framework for Newborn Screening in Low and Middle-Income Countries
-
Jul 3, 2026, 23:08For Jatinder Minhas, The Strength of Simulation Training Is Learning Together Across Disciplines – ESO
-
Jul 3, 2026, 22:47Khaled Musallam: Caring for Women with Thalassemia From Puberty to Pregnancy and Beyond
-
Jul 3, 2026, 21:25Matteo Foschi: Happy to Join the Italian Stroke Association Summer School
-
Jul 3, 2026, 20:39Maha Othman: Excited to Present on PPH for The Lancet Haematology Commission on Global Female Health